HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people

AIDS

Volumn 21, Issue 11, 2007, Pages 1415-1422

  Vitiello, Benedetto ^a   Goodkin, Karl ^b   Ashtana, Deshratn ^b   Shapshak, Paul ^b   Atkinson, J Hampton ^c   Heseltine, Peter N R ^d,f   Eaton, Elaine ^d   Heaton, Robert ^c   Lyman, William D ^e  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^f BECKMAN COULTER INC   (United States)

Author keywords

Cerebrospinal fluid; Cognitive impairment; HIV 1; Viral load

Indexed keywords

RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RNA, VIRAL; VIRAL LOAD;

EID: 34250893913     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328220e71a     Document Type: Article

References (23)

1. Singer EJ, Syndulko K, Fahy-Chandon BN, Shapshak P, Resnick L, Schmid P, et al. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 1994; 8:197-204.
2. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993; 43:2245-2252.
3. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology 1988; 38:9-14.
4. Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59:923-928.
5. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, et al. The HNRC 500: neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995; 1:231-251.
6. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004; 10:317-331.
7. Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzales R, Ellis RJ, Grant I. A multimodal assessment of driving performance in HIV infection. Neurology 2004; 63:1417-1422.
8. Wilkie FL, Goodkin K, Eisdorfer C, Feaster D, Morgan R, Fletcher MA, et al. Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998; 10:125-132.
9. McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42:689-698.
10. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997; 42:679-688.
11. Conrad AJ, Schmid P, Syndulko K, Singer EJ, Nagra RM, Russell JJ, Tourtellotte WW. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Aquir Immune Defic Syndr Hum Retrovirol 1995; 10:425-435.
12. Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, et al. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000; 54:927-937.
13. Heseltine PNR, Goodkin K, Atkinson JH, Vitiello B, Rochon J, Heaton RK, et al. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol 1998; 55:41-51.
14. Goodkin K, Vitiello B, Lyman WD, Atkinson JH, Heseltine PNR, Molina R, et al. Cerebrospinal and peripheral human immunodeficiency virus type I load in a multisite, randomized, double-blind, placebo-controlled trial of D-ala-peptide T-amide for associated cognitive-motor impairment. J Neurovirology 2006; 12:178-189.
15. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 2004; 56:301-307.
16. Carey CL, Woods SP, Gonzales R, Conover E, Marcotte TD, Grant I, Heaton RK. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004; 26:307-319.
17. Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, et al. Enhancing antiretroviral therapy for human deficiency virus cognitive disorders. Ann Neurol 2004; 56:416-423.
18. Marra CM, Lockhart D, Zunt JR, Perrin M, Coobs RW, Collier AC. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology 2003; 60:1388-1390.
19. Polis MA, Suzman DL, Yoder PC, Shen JM, Mican JM, Dewar RL, et al. Suppression of cerebrospinal fluid HIV burden in antiretroviral naïve patients on a potent four-drug antiretroviral regimen. AIDS 2003; 17:1167-1172.
20. Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD. Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 2004; 36:562-566.
21. McArthur J, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005; 4:543-555.
22. Kaul M, Lipton SA. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 2006; 4:307-318.
23. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, Kitahata M, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296:1498-1506.